Arnold & Porter Kaye Scholer, LLP
Patent reexamination counsel·5 ex parte reexams
Arnold & Porter Kaye Scholer, LLP has served as patent-owner counsel in 5 USPTO ex parte reexaminations, with 2 currently open. The firm most often represents Nike Inc. and Arriva Pharmaceuticals Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top patent owners represented
Outcome track record
How this firm's reexams resolve once a certificate issues: all claims confirmed, amended, mixed, or canceled.
- Certificate outcome split across every bucket
- Share of proceedings where claims survived
Practice metrics
Certificate rate, average pendency, and the open/closed split across the firm's full reexam docket.
- Certificate rate of closed proceedings
- Average pendency in months
Examiners & adversaries
Which examiners most often decide this firm's reexams, and which requesters most often challenge its patents.
- Most frequent examiners
- Top opposing requesters
Recent reexaminations (5)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/015,625 | Oct 24, 2025 | 9,986,781 | ARTICLE OF FOOTWEAR HAVING A TEXTILE UPPER | Nike Inc. | Open |
| 90/015,624 | Oct 22, 2025 | 9,918,511 | ARTICLE OF FOOTWEAR HAVING A TEXTILE UPPER | Nike Inc. | Open |
| 90/013,019 | Oct 8, 2013 | 5,954,743 | INTRAVASCULAR STENT | — | Closed |
| 90/013,018 | Oct 8, 2013 | 5,922,021 | INTRAVASCULAR STENT | — | Closed |
| 90/020,016 | Sep 13, 2012 | 7,247,704 | MULTIFUNCTIONAL PROTEASE INHIBITORS AND THEIR USE IN TREATMENT OF DISEASE | Arriva Pharmaceuticals Inc. | Closed |
Other reexam law firms
See the full reexam picture for Arnold & Porter Kaye Scholer, LLP
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.